Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Reduces Headcount by More than 400 in 2012

NEW YORK (GenomeWeb News) – PerkinElmer reduced its workforce by 437 people in 2012, it said in its Form 10-K filed with the US Securities and Exchange Commission this week.

The layoffs resulted from efforts by the company to shift resources to higher growth geographic regions and end markets, as well as a shift of certain operations into a new shared service center, and a realignment of operations, R&D, and production resources, it said.

As a result of the layoffs, PerkinElmer took restructuring charges totaling $24.4 million related to severance payments.

In 2011, the company eliminated 186 positions, it said in its Form 10-K, and took a charge of $11.3 million restructuring charges related to the layoffs.

PerkinElmer recently said that it posted $2.12 billion in revenues during 2012 with a profit of $69.9 million, or $.61 per share on a GAAP basis. On a non-GAAP basis EPS was $2.06.

Thermo Fisher Scientific this week also disclosed that it laid off 1,120 employees in 2012.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.